Avalon Bioventures Management, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- HQ
- CA
Avalon Bioventures Management, LLC says it invests in innovative science at the earliest stages, looking for white space opportunities that other investors often see as too early. The team includes Jay B. Lichter, Ph.D., Managing Partner, and several advisors.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Pre-seed, Seed | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Global | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Avalon BioVentures I, LP | approx. 2021 | $200M (Form D) | Follow-ons only |
03 · People across funds
- Jay Lichter, Managing Director of the General Partner of the Issuer
Avalon BioVentures I, LP (Named on Form D)
- Sanford Madigan, Managing Director of the General Partner of the Issuer
Avalon BioVentures I, LP (Named on Form D)
- Sergio Duron, Managing Director of the General Partner of the Issuer
Avalon BioVentures I, LP (Named on Form D)
- Tighe Reardon, Managing Director of the General Partner of the Issuer
Avalon BioVentures I, LP (Named on Form D)
- Eben Massari, Ph.D., Advisor
Avalon BioVentures I, LP (Team)
- Jason Roland, Ph.D., Advisor
Avalon BioVentures I, LP (Team)
- Jay B. Lichter, Ph.D., Managing Partner
Avalon BioVentures I, LP (Team)
- Jill Mooney, Ph.D., Advisor
Avalon BioVentures I, LP (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026